Introduction
Herpes simplex virus type 1 (HSV-1) is a large dsDNA virus with a genome of approximately 152000bp, encoding at least 70 distinct gene products (McGeoch et al., 1988) . Almost one-third of the encoded proteins are components of the virus particle. However, the roles of many of these proteins in virion assembly, structure and infectivity are unclear.
We have recently found that HSV-1 gene ULll encodes a myristylated virion polypeptide of unknown function (MacLean et al., 1989) . Myristylated virion proteins have been found in many different viruses, and in some cases myristylation is essential for virus replication (reviewed by Schultz et al., 1988) . Myristylation involves the cotranslational addition of the 14-carbon-chain saturated fatty acid, myristic acid, via an amide linkage to an N-terminal glycine residue. The myristic acid moiety may serve as a membrane anchor and could therefore be invisaged to play a role in envelopment or virus assembly at membranes. However, a number of observations suggest that myristic acid may also be specifically involved in protein-protein interactions. Not all myristylated polypeptides are associated with membranes; myristylation of pp60 sr¢ is necessary but not sufficient for membrane localization (Kaplan et specifically interacts with the myristylated N-terminal sequence of pp60 src (Resh, 1989; Resh & Ling, 1990 ) and the myristylated alpha subunits of certain guanine nucleotide-binding proteins only associate with phospholipid vesicles if the beta and gamma subunits are also present (Sternweis, 1986) .
Myristylated virion proteins have been proposed to be involved in many aspects of the virus life cycle, including roles in virion structure, the assembly, envelopment and release of virus particles, and virus entry into cells. For example, myristylation of retrovirus gag polypeptides is essential for either the assembly of virus particles at membranes (Rein et al., 1986) or the budding and release of preformed capsids (Rhee & Hunter, 1987; Delchambre et al., 1989; Gheysen et al., 1989) ; myristylation of the preS protein of duck hepatitis virus is required for virion infectivity, but not for assembly or release (Macrae et al., 1991) ; and myristylation of poliovirus protein VP4 is required for both virion assembly and infectivity (Marc et al., 1990; Moscufo et al., 1991) .
Homologues of HSV-1 ULll exist in other herpesviruses. Open reading frames (ORFs) corresponding to ULll are present in HSV-2, varicella-zoster virus, Epstein-Barr virus and possibly human cytomegalovirus (HCMV; Draper et al., 1986 , Davison & Scott, 1986 Baer et al., 1984; Chee et al., 1990) ; all five ORFs contain al., 1990); a protein present in the plasma membrane a consensus sequence for myristylation (Chow et al., 1987; Towler et al., 1988) , and both HSV-1 and HSV-2 possess myristylated virion components (MacLean et al., 1989) . Therefore, we considered it possible that the HSV-1 ULll polypeptide could have an important function. Here we describe the further characterization of the UL11 polypeptide and the growth properties of a mutant virus lacking this myristylated protein.
Methods
Cells. BHK-21 clone 13 (C13) cells (Macpherson & Stoker, 1962) , grown in Eagle's medium supplemented with 10% newborn calf serum, were used throughout.
Virus. HSV-1 strain 17syn ÷ (Brown et al., 1973) was the wild-type (wt) virus strain used in this study.
Plasmids. Plasmid pFJ5ACAT contains within a 4-2kbp XbaI fragment both the lacZ gene from Escherichia coli, under the control of the simian virus 40 (SV40) early promoter and linked to the SV40 early polyadenylation signal, and the HSV-2 IE5 polyadenylation signal downstream from, and in the opposite orientation to, the SV40 polyadenylation signal (Rixon & McLauchlan, 1990) . Plasmid construction and propagation were carried out by standard procedures (Maniatis et aL, 1982) . In the following descriptions, HSV-1 DNA sequences are numbered according to McGeoch et al. (1988) .
A HinclI fragment (residues 22877 to 26684) containing the UL11 ORF (residues 25093 to 24803, including the termination codon) was cloned between the XbaI and Sinai sites of pUC19, generating plasmid pC190. An XbaI linker (pCTCTAGAG) was inserted within the unique EcoRV site, between residues 24984 and 24985. The 4-2 kbp XbaI fragment from pFJ5ACAT was inserted into this Xbal site, oriented so that it could provide an alternative polyadenylation signal for the upstream genes (ULI2, UL13 and ULI4) which are 3'-coterminal with ULll. This plasmid was designated pC199. All plasmids were propagated in E. coil strains DH5 or DH5c~ (Gibco-BRL).
Antiserum. The anti-ULll serum, raised against the C-terminal 12 amino acids of the ULll ORF, has been described previously (MacLean et al., 1989) .
Construction of the UL11 insertion mutant and revertant viruses.
Transfections were carried out according to the procedure of Graham & van der Eb (1973) , as modified by Stow & Wilkie (1976) . BHK C13 cells were cotransfected with wt HSV-1 strain 17syn + DNA and various amounts of linearized plasmid pC199 as described previously (MacLean et al., 1991) . Once c.p.e, was relatively widespread, the cells were scraped into the medium and sonicated, and the virus yield was then titrated under methylcellulose. Cells were infected with approximately 20 p.f.u, virus/50 mm Petri dish, and overlaid with Eagle's medium containing 2% newborn calf serum, 0.64% Noble agar and 1 raM-X-Gal. Virus from individual blue plaques was isolated and subjected to several further rounds of plaque purification. The genome structure of the virus isolates was determined by restriction enzyme analysis (MacLean et al., 1991) before virus stocks were grown. The virus isolated was designated UL11-1acZ.
One UL11-1acZ isolate was chosen for further study and used to generate a UL11 revertant virus. Cells were cotransfected with UL11-lacZ virus DNA and various amounts of linearized plasmid pCl90, as before. Virus from individual white plaques was isolated and subjected to several further rounds of plaque purification. Again, one isolate (UL11-rev) was chosen for further study.
Purification of virus DNA for polymerase chain reaction (PCR)
amplification. Purification of virus DNA from wt virus or single plaque isolates was based on the method of Lonsdale (1979) , as described by MacLean et al. (1991) , with the exception that the virus was grown in the presence of Eagle's medium containing 2% newborn calf serum and no radiolabel.
PCR amplification and DNA sequence analysis. Oligonucleotide primers which bracket the UL11 ORF were synthesized on a Biosearch 8600 DNA synthesizer: primer A (rightward) represents HSV-1 DNA residues 24774 to 24793 (5' CGACCGTATACAGAACATTG 3'); primer B (leftward) represents HSV-1 DNA residues 25122 to 25103 (5' CTGGCATTCGACGACACGCT 3'). PCR amplification was carried out in a final volume of 50 Ixl containing 1 p.M-oligonucleotides, 200 ~tM each dNTP, AmpliTaq (Perkin-Elmer Cetus) and 10 ng HSV-1 DNA using a Techne Dri-block and a protocol involving: one cycle at 95 °C for 5 rain, 55 °C for 1.5 min, 73 °C for 2 min; 34 cycles at 95 °C for 1 min 10 s, 55 °C for 1-5 min, 73 °C for 2 min; and one cycle at 95 °C for 1 min 10 s, 55 °C for 1.5 min, 73 °C for 10 min. The PCR products were separated on 3~ Nu-Sieve agarose gels (FMC Bioproducts). Bands of the expected size (349 bp) were obtained, gel slices excised and melted, and the DNA was recovered by phenol extraction and ethanol precipitation. Y-Phosphate groups were added with polynucleotide kinase, and the reactions were then heated at 55 °C for 5 rain, passed through Sephadex G-50 spun columns and ethanolprecipitated, The PCR-amplified DNA was then inserted into the SmaI site of M13mp8, and DNA sequences were obtained in both directions using universal primer and primers A and B (Sanger et al., 1977) .
Preparation of infected cell extracts. Confluent cell monolayers in 50 mm
Petri dishes were infected with 20 p.f.u./cell in Eagle's medium containing 5~ newborn calf serum. The virus was adsorbed for 1 h at 37 °C and the infected cells were then washed twice with, and subsequently maintained in, Eagle's medium containing one-fifth the normal concentration of methionine and 2~ newborn calf serum. [35S]Methionine (Amersham; specific activity > 1000 Ci/mmol) was added directly to the cells at a final concentration of 50~tCi/ml; [3H]myristic acid (Amersham; specific activity 40 to 60 Ci/mmol), supplied in ethanol, was dried under a stream of nitrogen, redissolved in a small volume of ethanol and added at 125 to 250 ~tCi/ml. The cells were then harvested 24 h p.i. For pulse-labelling, [3sS]methionine was added at 150 ~tCi/ml for 2 h at various times p.i.
Infected cell polypeptides were harvested by washing the cells twice with PBS and then adding 0.5 ml extraction buffer containing 100 mMTris-HC1 pH 8, 10% glycerol, 0.5~ NP40, 0-5% sodium deoxycholate and 0.2mM-PMSF. Cell debris was pelleted by centrifugation at 11000 gfor I0 rain in a Beckman microfuge, and the supernatant was stored at -70 °C until use.
Subcellularfractionation. Subcellular fractionation was based on the method described by Bryant &Ratner (1990) with minor modifications. Cell monolayers were rinsed twice with PBS and once with distilled water before being scraped into homogenization buffer (20 mM-Tris-HC1 pH 8, 10 mM-MgCIz, 0-5 mM-EDTA, 7 mM-2-mercaptoethanol) and swollen on ice for 20 rain. The cells were then disrupted by Dounce homogenization (50 strokes) and centrifuged at 2000 r.p.m, for 3 rain at 4 °C in a Fisons Coolspin to remove nuclei and any intact cells. The supernatant material was adjusted to 150 mMNaC1 and centrifuged in a Sorvall Ti50 rotor at 45 000 r.p.m, for 30 min at 4 °C. The supernatant (cytosol) was removed, and the pellet (total membranes) was resuspended in homogenization buffer containing 150 mra-NaC1. A sample of the total membrane fraction was then adjusted to 1 M-NaC1 and centrifuged as before. The supernatant contained those proteins which bound only at the low ionic strength, whereas the pelleted material contained proteins which bound to membranes at high ionic strength. Samples were diluted 1 : 1 with 2 x concentrated extraction buffer for immunoprecipitation.
Immunoprecipitation. Immunoprecipitation reactions were carried out as described previously (MacLean et at., 1989) .
Purification of virus particles. The procedure used was essentially that described by Szilfi.gyi & Cunningham (1991) . Briefly, monolayers of BHK C13 cells in 80 oz roller bottles were infected with 1000 p.f.u. HSV-1 strain 17syn +, incubated at 31 °C for 2 to 3 days until c.p.e, was evident, and then labelled with [3H]myristic acid (125~tCi/ml) or [35S]methionine (25 ~Ci/ml) as described above. Infection was continued at 31 °C for a further 2 to 3 days until c.p.e, was advanced. Culture supernatants were centrifuged in a Fisons Coolspin centrifuge (2000 r.p.m., 30 min, 4 °C) to remove cell debris. Virions were pelleted by centrifugation in a Sorvall GSA rotor (12000 r.p.m., 2h, 4°C), resuspended very gently in a small volume of Eagle's medium without phenol red and layered on a 35 ml continuous 5 to 1570 Ficoll gradient which was centrifuged in a Sorvall AH627 rotor at 12000 r.p.m, for 2 h at 4 °C. Two bands were visible. The lower virion band was collected by side puncture, diluted and pelleted by centrifugation in a Sorvall AH627 rotor at 21000 r.p.m, for 16 h at 4 °C. The upper more diffuse band, which contained nucleocapsid-free tegument-envelope structures (termed L particles), was also collected by side puncture, but was rebanded on a second 5 to 157o Ficoll gradient before pelleting as described above. Purified virions and L particles were resuspended in PBS and analysed by electron microscopy.
NP40 extraction of virions.
Purified virions were incubated in the presence of 5 % NP40, 600 mM-NaCI for 30 rain at room temperature, diluted fivefold with 20 mM-Tris-HCl pH 7.5, and then centrifuged in a Sorvall SS34 rotor at 11000 r.p.m, for 2 h at 4 °C .
The non-soluble pellet material was resuspended in denaturation buffer (50 mM-Tris-HC1 pH 6.7, 270 SDS, 700 mM-2-mercaptoethanol, 1070 glycerol and 1% bromophenol blue) in a volume equivalent to the supernatant fraction. Samples were analysed on 7-5 to 1570 SDSpolyacrylamide gels (Marsden et al., 1978) .
In vitro phosphorylation of purified virions. Purified virions were treated with 0.05% NP40 in 10 mM-Tris-HCl pH 7.5, 1 mM-MgCI2, 1 mM-DTT for 60 min on ice, diluted 1 : 1 with 10 mM-Tris-HCl pH 7.5, 1 mM-MgCI:, 1 mM-DTT, and stored at -70 °C until use. For in vitro phosphorylation, ~,0 ~1 of N P40-treated virions was diluted 10-fold in a buffer of final concentration 50 mM-Tris-HCl pH 7.5, 10 mM-MgClz, 1 mM-DTT, 500 mM-NaC1, and incubated for 60 min at 37 °C in the presence of 201aCi [y32p]ATP (Amersham; specific activity > 5000 Ci/mmol). The samples were solubilized in extraction buffer before immunoprecipitation with anti-ULl 1 serum.
Fluorography. SDS-polyacrylamide gels were treated with En3Hance (New England Nuclear), dried and exposed to Kodak X-Omat XS-1 film at -70 °C.
Results
Previously, we have identified the products of HSV-1 gene UL11 as a family of at least three myristylated virion polypeptides of a p p a r e n t Mr 13K to 16K ( M a c L e a n et al., 1989) , the function of which was u n k n o w n . As one approach to establishing their role in the virus life cycle, we wished to characterize these polypeptides further. Proteins from the infected cell extracts (lanes 1) were then precipitated with anti-UL11 serum in the presence (lanes 3) or absence (lanes 2) of the relevant peptide, and analysed on 7.5 to 15% SDS-polyacrylamide gels. The UL11 polypeptides are indicated.
Relationship between the three different Mr species
Although wt HSV-1 strain 17syn ÷ apparently expresses three electrophoretically distinguishable UL11 polypeptide species, we had noted previously that several HSV-1/HSV-2 intertypic r e c o m b i n a n t s encoding the HSV-1 U L l l O R F did not express the lowest M r form. Therefore, to determine whether the HSV-1 stock used was heterogeneous with respect to the UL11 polypeptides encoded, several individual plaque isolates were purified. Cells were infected with either the purified isolates or the wt virus stock, labelled with [3H]myristic acid, and cell extracts were prepared and i m m u n o p r e c ipitated with anti-UL11 serum (Fig. 1) . As expected, the wt virus stock expressed all three U L l l polypeptide species; in contrast, the majority of isolates expressed only the two higher Mr species (nine of 11 isolates; designated 17a), whereas two isolates expressed the lowest Mr species alone (designated 17b). No plaquepurified isolate was found to express all three species. Cells were infected with the wt virus stock or two representatives of each of the 17a and 17b types, and virus D N A was prepared. The U L l l O R F was then amplified by P C R , cloned into M13 and the D N A sequence was determined. The sequence of the wt HSV-1 D N A was found to be identical to that published previously ( M c G e o c h et al., 1986), as was the sequence of the 17a isolates. The 17b isolates differed only at a single nucleotide; the wt sequence residue C (24979) was replaced by T (results not shown). This changes codon 39 in the leftward-oriented UL11 O R F from G A G to A A G , resulting in a glutamic acid to lysine change in the protein.
Therefore the wt HSV-1 strain 17syn ÷ stock represents a mixture of at least two virus genotypes. Most of the work described below was carried out using this original wt virus stock. 
Kinetics of synthesis of the UL11 polypeptides
To determine the kinetics of synthesis of the U L l l polypeptides, infected cells were pulse-labelled with [35S]methionine for 2 h at various times p.i. Cell extracts were then i m m u n o p r e c i p i t a t e d with a n t i -U L l l serum (Fig. 2a) . The U L I 1 polypeptides were detected early in infection (0 to 2 h; barely visible in the figure shown), their synthesis reaching a peak around 6 to 8 h, and declining thereafter. Following infection in the presence of phosphonoacetic acid (PAA), an inhibitor of viral D N A replication, the UL11 polypeptides were synthesized, but at a reduced level (Fig. 2b) . Thus, U L I 1 would a p p e a r to behave as a delayed early gene.
Post-translational modification of the UL11 polypeptides

To determine whether the U L l l polypeptides are p h o s p h o r y l a t e d or glycosylated, cells were infected and labelled with [32p]orthophosphate, [14C]glucosamine or
[3H]mannose, and cell extracts were then immunop r e c i p i t a t e d with a n t i -U L l l serum. All three U L l l polypeptides labelled weakly, but consistently, with [3H]mannose. There was no a p p a r e n t incorporation of the other radiolabels (results not shown). In our hands, HSV polypeptides labelled very poorly with [32p]orthophosphate in vivo. Therefore, we investigated whether the U L l l polypeptides could be phosphorylated in vitro. Purified virions were incubated with [7 -3 ZP]ATP under conditions that allow the p h o s p h o r y l ation of a n u m b e r of virion proteins; all three U L l l polypeptides were p h o s p h o r y l a t e d (Fig. 3) . Interestingly, the a p p a r e n t homologue in H C M V , identified only on the basis of its genome location (Chee et al., 1990) , is a virion protein which is p h o s p h o r y l a t e d in vitro (Meyer et al., 1988) . The samples were then solubilized in extraction buffer before precipitation with anti-UL11 serum in the presence (lanes 2, 4, 6 and 8) or absence (lanes 1, 3, 5 and 7) of the relevant peptide. Lane 9, whole cell extract; lanes 1 and 2, cytosol; lanes 3 and 4, total membrane fraction; lanes 5 and 6, proteins that bind to membranes at low ionic strength only; lanes 7 and 8, proteins that bind to membranes at high ionic strength (1 M-NaC1). The ULll polypeptides are indicated. and unbroken cells removed, and the remaining components divided by centrifugation into a soluble cytosol fraction and a membrane-containing fraction. The UL11 polypeptides were detected by immunoprecipitation and appeared to be predominantly membrane-associated (Fig. 4) . Treatment of the m e m b r a n e fraction with 1 MNaC1 did not release the U L I 1 polypeptides, suggesting that they were bound with relatively high affinity. Similar results were obtained if the cells were labelled with [3H]myristic acid (not shown).
Location of the ULI1 polypeptides within the infected cell
Location of the UL11 polypeptides within the virus particle
A procedure for isolating non-infectious virus-like particles lacking a nucleocapsid (L particles) has been described recently (Szilfigyi & Cunningham, 1991) . Virus was grown in the presence of either [3~S]methionine or [3H]myristic acid, and both intact virions and L particles were purified. The L particles appeared to lack the capsid polypeptides (e.g. 155K and 12K), but contained all the tegument and envelope proteins of the intact virion (Fig. 5) . The myristylated virion species were found to be components of these L particles.
To determine whether the myristylated species are associated with the virion envelope, purified virions were solubilized using NP40 (Fig. 6) . Capsid proteins were recovered exclusively in the non-soluble pellet material, whereas tegument proteins were found to some extent in both fractions (e.g. 65K) and envelope proteins (e.g. gB and gD, running below 155K and 65K, respectively) were found almost exclusively in the supernatant. The UL11 polypeptides were found in both fractions, to various extents and this would suggest that they are components of the virion tegument. 3 and 4) . Intact virions (lanes 1 and 3) and L particles (lanes 2 and 4), purified as described in Methods, were analysed on a 7.5 to 15~ SDS-polyacrylamide gel. Coomassie blue staining confirmed that the myristylated virion and L particle profiles were identical to those labelled with [35S]methionine, and that similar levels of protein had been loaded in each lane (not shown). Mr values are shown to the left. The UL11 polypeptides are indicated.
Construction of a ULl l insertion mutant and a revertant virus
To investigate more directly the role of the U L t l polypeptides in the virus life cycle, we inserted the E. coli lacZ gene within the UL11 O R F (see Methods). Virus isolates were selected on the basis of their blue plaque morphology and then purified (designated UL11-1acZ). The wt UL11 O R F was then recombined into the UL11-lacZ genome, to generate a revertant virus (UL11-rev). The genome structure of the U L I I -l a c Z and UL11-rev viruses was confirmed by restriction enzyme analysis (results not shown). 
Polypeptide profiles of UL11 insertion mutants
Insertion of the laeZ gene disrupts the UL11 O R F at codon 37. If an N-terminal truncation product was synthesized, it would be expected to be 38 amino acids in length, sharing the first 37 amino acids of the wt virus UL11 product and hence the myristylation signal. The estimated size of such a product is 5K to 6K. Cells were infected with either wt virus or one of three separate insertion mutant isolates and labelled with [3H]myristic acid. Virus-induced polypeptides were analysed on polyacrylamide gels alongside a set of radioactive Mr markers (Fig. 7) . The UL11-1acZ viruses did not accumulate the intact 13K to 16K myristylated polypeptides, nor did they appear to accumulate a truncated myristylated protein as no novel myristylated species of > 2-5K was apparent, even after very long exposures of the gel.
One UL11-1acZ isolate was subsequently chosen for further study. This isolate was used to generate the revertant virus used below. The UL11-rev virus synthesized only the two higher Mr UL11 polypeptide species (results not shown).
In vitro growth properties of ULl l-lacZ
The UL11-1acZ virus was viable but slightly impaired for growth in tissue culture, and had a small plaque morphology. Following infection at low multiplicity, UL11-1acZ reached a final yield five-to 20-fold less than that of the wt parent or revertant viruses, but showed a similar pattern of growth in terms of the duration of the lag and growth phases (Fig. 8) . At high m.o.i., growth of UL11-1acZ was two-to 10-fold lower than that of the wt viruses (not shown). The UL11-1acZ virus did not have a restricted host-range phenotype (for growth in BHK C13, Flow 2002, Vero, BSC-1, MDCK or 3T6 cells), or a temperature-sensitive phenotype (for growth in BHK C13 cells at 31 °C, 37 °C, 38-5 °C or 39.5 °C), nor was it more thermolabile than the wt viruses (results not shown).
Discussion
Previously, it has been shown that HSV-1 gene ULll encodes a family of myristylated virion proteins (MacLean et al., 1989) . In this communication, we have demonstrated that the ULll polypeptides are synthesized as delayed early gene products, label very weakly with [3H]mannose and are phosphorylated in vitro. They associate with membranes within the infected cell and appear to be components of the virion tegument.
Insertional mutagenesis of the UL11 ORF results in a virus mutant impaired for growth in tissue culture. Thus, the UL11 products would appear to be important, but not essential, for virus replication.
Three ULll polypeptide species are detectable in extracts from cells infected with HSV-1 strain 17syn ÷. The lowest Mr species apparently results from the presence of a minor population of virus genotypes within the HSV-1 strain 17syn ÷ stock (designated 17b), which encodes an altered UL11 ORF. The polypeptide differs from the two higher Mr species at only a single amino acid (amino acid 39), representing an acidic to basic change (glutamic acid to lysine) within a region of the protein which is highly acidic, and which is predicted to be s-helical (Chou & Fasman, 1978) ; the alteration reduces the predicted s-helical potential of this region. The change in charge or protein structure is presumably responsible for the higher electrophoretic mobility, either directly or by altering post-translational modification(s).
The 17a virus isolates (Glu 39) encode two electrophoretically distinguishable UL 11 polypeptide species. These apparently have common N and C termini (MacLean et al., 1989) , and may differ in the nature and/or extent of their post-translational modification. In contrast, the 17b virus isolates (Lys 39) encode a single UL11 polypeptide species, perhaps again suggesting that the amino acid alteration affects the processing of the ULll polypeptide. However, no obvious differences have been observed; all three species label weakly with [3H]mannose, and are phosphorylated in vitro. The single amino acid change does not appear to influence virus growth properties, as the 17a and 17b isolates have similar plaque morphology and behave indistinguishably in low m.o.i, growth experiments (unpublished observations).
One possible role for a myristylated virion protein may be in facilitating virus envelopment. Although the UL11 polypeptides appear to reside within the virion tegument, they associate with membranes within the infected cell, suggesting that they might also interact with the virion envelope. Attempts to localize more precisely the UL11 polypeptides by immunoelectron microscopy are in progress.
Insertion of the lacZ gene within the UL11 ORF produced a virus mutant which is impaired for growth compared to the wt parent and revertant viruses, and has a small plaque morphology. Since we have constructed an insertion rather than a deletion mutant, one could argue that a partially functional truncated product is synthesized. However, our results suggest that this is unlikely; we can not detect a novel myristylated species (i.e. a product containing the N terminus, the site of myristic acid addition) or precipitate any novel [3SS]methionine labelled species with the anti-ULll serum (i.e. a product containing the C terminus; results not shown). Thus, the ULll ORF does appear to be inactivated.
Myristylation of virion components is essential for the replication of certain mammalian retroviruses, poliovirus and duck hepatitis B virus (Rein et al., 1986; Rhee & Hunter, 1987; Marc et al., 1989; Macrae et al., 1991) . In contrast, although required for efficient replication, the myristylated virion proteins of HSV-1 are not essential for virus growth in tissue culture (however, this study does not address the role of myristylation per se). Compared to the former viruses, herpes simplex virions are large and complex structures, and contain many virus-encoded proteins (reviewed by Dargan, 1986) . Several of these proteins have been found to be nonessential for virus growth in tissue culture (for example, UL41, UL47, US8, US9 and USI0; Longnecker & Roizman, 1986; Umene, 1986; Barker& Roizman, 1990; Fenwick & Everett, 1990 ), yet their ORFs are conserved in other herpesviruses (McGeoch et al., 1988) . These apparently non-essential virion proteins presumably have important functions in the natural life cycle of the virus.
The precise stage(s) of the virus life cycle at which the UL11 polypeptides play a role is uncertain. The UL11-lacZ virus does not have a restricted host-range or a temperature-sensitive phenotype, nor is it apparently any more thermolabile than wt virus. Although the latter two observations might suggest that the absence of the UL11 polypeptides does not significantly destabilize the virus particle, preliminary electron microscopy studies suggest that the mutant particles are less well structured than their wt parent (J. Aitken, unpublished observations). We are currently investigating whether the UL11-lacZ virus shows any impairment in its rate of adsorption or penetration.
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